The first clinical attempt to make human beings biologically younger is no longer a thought experiment. A small gene therapy trial, cleared quietly by regulators in the United States, is now moving ...
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have treated the first participant in a clinical trial exploring whether older cells ...
Add Yahoo as a preferred source to see more of our stories on Google. Technologies to refresh ageing tissue have become attractive targets for investors. Yuancheng Ryan Lu could barely breathe while ...
Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...
A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...
An international team of scientists has developed a method to measure biological aging with unparalleled precision that has the potential to change the way we approach aging and age-related diseases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results